Biotech Startups

Epitomee develops ingestible therapeutic devices and platforms that deliver targeted therapies along the gastrointestinal tract to manage metabolic diseases, obesity, and deliver biologics. The company combines mechanical and ingestible morphology platforms with therapeutic agents to achieve specific localization with limited side effects.

2 investors

Erisyon is a biotechnology company that develops technology to advance scientific and health discoveries, building on research from the University of Texas at Austin's Center for Systems and Synthetic Biology. It was founded in 2018 by a group of technologists and entrepreneurs.

2 investors

EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.

2 investors

Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.

2 investors

Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development. It also runs its own therapeutic pipeline and operates a cGMP-accredited RNA manufacturing facility in Niel, Belgium.

2 investors

Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.

2 investors

Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers. Its pipeline is built on the ARTEMIS and E-ALPHA technology platforms aimed at targeting cancer-specific antigens.

2 investors

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions. The company positions itself as a provider of comprehensive, research-driven solutions to CGT challenges.

2 investors

EVANIUM develops OPTISOLV®, an IP-protected drug-delivery technology that improves the water solubility, stability, absorption, and taste of plant-based active ingredients such as polyphenols and flavonoids. The technology is aimed at brands making food, nutraceutical, pharmaceutical, and personal care products, with development in Germany and production in Europe.

2 investors

Evaxion is a biotechnology company that uses artificial intelligence and machine learning to model the immune system and design personalized and precision vaccine candidates. Its AI prediction models focus on cancer and infectious diseases, identifying vaccine targets for partners developing therapeutics.

2 investors

Evecxia Therapeutics develops 5-HTP-based drugs using proprietary drug delivery technologies designed to increase brain serotonin production as adjunctive treatments for depression and other mental disorders. Its therapies target patients with disabling mental illness not adequately treated by existing antidepressants such as SSRIs and SNRIs.

2 investors

2 investors

Everest Medicines is a biopharmaceutical company focused on discovering, developing, and commercializing therapies and vaccines, with a pipeline of major products and in-house discovery and manufacturing capabilities.

2 investors

Evergreen produces cultivated beef intended to be blended with traditional beef (at 10–50%) to help food producers manage costs and reduce exposure to cattle-price volatility. Its cultivated meat is made without added antibiotics, hormones, growth factors, or plant fillers and is designed to match the taste and texture of conventional beef.

2 investors

EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.

2 investors

Evolva (EvoNext Holdings SA / Evolva Holding AG) develops and markets flavour and fragrance products. The page is an investor relations section providing financial information and shareholder resources for the publicly listed company.

2 investors

Evolved by Nature develops Activated Silk®, a biotech platform that extracts and engineers novel molecules from natural silk using its proprietary NoviCulture process to create biobased alternatives for applications in skincare, coatings, and materials. The company targets brands and manufacturers seeking sustainable, renewable replacements for petrochemical-derived ingredients and synthetic materials.

2 investors

Evoralis develops enzymatic recycling solutions using enzyme engineering and molecular biology to advance circular economy practices.

2 investors

Exact Sciences develops molecular diagnostic tests for cancer screening and detection, including multitarget stool DNA testing for colorectal cancer and multigene assays for breast cancer recurrence. The company serves patients and healthcare providers in the cancer diagnostics field.

2 investors

Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis). The company's projects have been supported by public and non-profit funding programs.

2 investors

Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.

2 investors

Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.

2 investors

ExoFlare builds a biosecurity platform designed to help intensive animal and food production operations manage disease risks and maintain market access during livestock disease events.

2 investors

EXOKĒRYX develops semiconductor-based technology for isolation, characterization, and analysis of extracellular vesicles to enable earlier disease and cancer detection in research settings. The company serves biomedical researchers working on disease detection and diagnostics using chip-based sensors and dielectrophoresis technology.

2 investors